期刊文献+

CRISPR-Cas9系统定向编辑TCR基因的sgRNA筛选 被引量:2

Selection of sgRNA for Efficient Editing of TCR Gene by CRISPR-Cas9 System
下载PDF
导出
摘要 为构建靶向T细胞抗原受体(T Cell Receptor,TCR)基因的CRISPR-Cas9基因组编辑系统,基于p X458质粒构建靶向TCR基因β链C区的CRISPR-Cas-sgRNA质粒,将其转染Hep G2细胞系,用流式细胞术检测转染效率;转染48 h后提取Hep G2细胞基因组DNA,扩增含有编辑位点的片段,测序分析该片段的峰图改变;对出现双峰的扩增片段做T-A克隆后测序分析,确定基因编辑发生的位置,并结合转染效率计算基因编辑效率.结果表明,成功构建含有3种sgRNA序列(N1、N2、S1)的p X458-sgRNA质粒,其转染效率分别为38.5%(N1)、39.7%(N2)和24.2%(S1);基因组PCR产物测序分析发现,S1组扩增片段在打靶位置出现杂峰;T-A克隆测序发现,20克隆有4个发生了基因编辑(20%),结合转染效率(24.2%)可知,编辑效率约为83%.可见,本文成功构建靶向TCR基因的CRISPR-CassgRNA质粒,并鉴定出基因编辑效率较高的一种sgRNA序列. To establish a TCR-targeted CRISPR-Cas9 system for study of TCR functions, the CRISPR-Cas-sgRNA constructs targeting TRBC were made based on pX458 vector and transferred into HepG2 . The transfection efficiencies were detected by flow cytometry ( FCM) after 48 h. Subsequently, the genomic DNA of HepG2 was extracted and a fragment covering target sequence was amplified by PCR and analyzed by se-quencing. The fragment exhibiting overlapping peaks in target sequence was subject to T-A cloning. The se-quencing results were then analyzed to confirm the occurrence of indel and calculate the editing efficiency. The results showed that three pX458-sgRNA constructs (N1、 N2、 S1) were made. The transfection efficien-cies were 38. 5% (N1), 39. 7% (N2) and 24. 2% (S1), respectively. Sequencing results of S1 fragment exhibited overlapping peaks. After cloning and sequencing, 4 of 20 S1 clones showed sequence alteration. Considering the 24. 2% transfection efficiency, the indel efficiency induced by the sgRNA-S1 is approximate 83%. CRISPR-Cas-sgRNA constructs targeting TRBC were successfully made and a type of sgRNA has been identified for high-efficiency genome editing.
出处 《集美大学学报(自然科学版)》 CAS 2015年第4期265-270,共6页 Journal of Jimei University:Natural Science
基金 国家自然科学基金资助项目(31100664 31300737 81303292)
关键词 T细胞抗原受体 靶向 基因组 编辑 TCR targeting clustered regularly interspaced short palindromic repeats (CRISPR) genome editing
  • 相关文献

参考文献22

  • 1WANG X, RIVIRE I. Manufacture of tumor-and virus-specific T lymphocytes for adoptive cell therapies [ J]. Cancer Gene Ther, 2015, 22(2) : 85-94.
  • 2CLAY T M, CUSTER M C, SACHS J, et al. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity [ J]. J hnmunol, 1999, 163(1 ) : 507-513.
  • 3COOPER L J, KALOS M, LEWINSOHN D A, et al. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes [ J]. J Virol, 2000, 74(17) : 8207-8212.
  • 4HEEMSKERK M H, HOOGEBOOM M, DE PAUS R A, et al. Redirection of antileukemic reactivity of peripheral T lym- phocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a con- served alpha joining region [ J ]. Blood, 2003, 102 (10) : 3530-3540.
  • 5MORGAN R A, DUDLEY M E, YU Y Y, et al. High efficiency TCR gene transfer into primary human lymphocytes af- fords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens [J]. ] Immunol, 2003,171(6) : 3287-3295.
  • 6XUE S A, GAO L, HART D, et al. Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-trans- duced human T cells [J]. Blood, 2005, 106(9) : 3062-3067.
  • 7PEGRAM H J, JACKSON J T, SMYTH M J, et al. Adoptive transfer of gene-modified primary NK cells can specifically inhibit tumor progression in vivo [J]. J Immunol, 2008, 181(5) : 3449-3455.
  • 8PHAN G Q, ROSENBERG S A. Adoptive cell transfer for patients with metastatic melanoma : the potential and promise of cancer immunotherapy [J]. Cancer Control, 2013, 20(4) : 289-297.
  • 9SHAO H, ZHANG W, HU Q, et at. TCR mispairing in genetically modified T cells was detected by fluorescence reso- nance energy transfer [J]. Mol Biol Rep, 2010, 37(8) : 3951-3956.
  • 10SOMMERMEYER D, NEUDORFER J, WEINHOLD M, et al. Designer T cells by T cell receptor replacement [ J ]. Cur J Immunol, 2006, 36: 3052-3059.

二级参考文献5

共引文献12

同被引文献1

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部